These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3128820)

  • 1. Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.
    See RE; Levin ED; Ellison GD
    Psychopharmacology (Berl); 1988; 94(3):421-7. PubMed ID: 3128820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-induced oral movements in rats: methodological issues.
    Levy AD; See RE; Levin ED; Ellison GD
    Life Sci; 1987 Sep; 41(12):1499-506. PubMed ID: 2887997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic neuroleptics alter the effects of the D1 agonist SK&F 38393 and the D2 agonist LY171555 on oral movements in rats.
    Ellison G; Johansson P; Levin E; See R; Gunne L
    Psychopharmacology (Berl); 1988; 96(2):253-7. PubMed ID: 2906749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia.
    See RE; Ellison G
    Eur J Pharmacol; 1990 Jun; 181(3):175-86. PubMed ID: 2384130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.
    See RE; Ellison G
    Psychopharmacology (Berl); 1990; 100(3):404-12. PubMed ID: 2315437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic administration of typical, but not atypical neuroleptics induce persisting alterations in rest-activity cycles in rats.
    Ellison G; See RE
    Pharmacol Biochem Behav; 1990 Aug; 36(4):807-11. PubMed ID: 1977177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tremorous mouth movements in rats administered chronic neuroleptics.
    Ellison G; See R; Levin E; Kinney J
    Psychopharmacology (Berl); 1987; 92(1):122-6. PubMed ID: 2885880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia.
    Ellison G; See RE
    Psychopharmacology (Berl); 1989; 98(4):564-6. PubMed ID: 2570435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior of rats during one-year administration of fluphenazine and subsequent withdrawal period.
    Trzeciak HI; Herman ZS; Szkilnik R; Opiełka L; Laskawiec G; Kryk A; Kmicińska M; Stańda J; Obuchowicz E; Bień E
    Pol J Pharmacol Pharm; 1986; 38(1):9-20. PubMed ID: 3763488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors.
    See RE; Aravagiri M; Ellison GD
    Life Sci; 1989; 44(3):229-36. PubMed ID: 2536879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral movement patterns induced in rats by local infusions into striatum depend upon the regimen of prior neuroleptic exposure.
    Ellison G; Liminga U; Keys A
    Psychopharmacology (Berl); 1995 Sep; 121(2):259-66. PubMed ID: 8545532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic haloperidol effects on oral movements and radial-arm maze performance in rats.
    Levin ED; Galen DM; Ellison GD
    Pharmacol Biochem Behav; 1987 Jan; 26(1):1-6. PubMed ID: 3562481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia.
    See RE
    Neuropsychopharmacology; 1993 Sep; 9(2):101-9. PubMed ID: 8216693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose.
    Egan MF; Hyde TM; Kleinman JE; Wyatt RJ
    Psychopharmacology (Berl); 1995 Jan; 117(1):74-81. PubMed ID: 7724705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs.
    Weinstein D; See RE; Ellison G
    Pharmacol Biochem Behav; 1989 Apr; 32(4):1057-60. PubMed ID: 2798529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities.
    Mithani S; Atmadja S; Baimbridge KG; Fibiger HC
    Psychopharmacology (Berl); 1987; 93(1):94-100. PubMed ID: 2888156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
    Ossowska K; Wolfarth S
    Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranigral stimulation of oral movements by [Pro9] substance P, a neurokinin-1 receptor agonist, is enhanced in chronically neuroleptic-treated rats.
    Liminga U; Gunne LM
    Behav Brain Res; 1993 Oct; 57(1):93-9. PubMed ID: 7507330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.